TNFRSF1A and ankylosing spondylitis: After Bonferroni correction (PMR-Wald < 6.82 × 10−6), we found that genetically proxied TNFRSF1A inhibition decreased white blood cell counts (total leucocytes, eosinophils, monocytes, basophils, and lymphocytes), decreased platelet count and was protective for Ankylosing spondylitis.